Condition: Medullary Thyroid Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
This is a real world study aiming to observe the efficacy and safety of Anlotinib capsules in patients with advanced medullary thyroid carcinoma, and to summarize the treatment experience in a broad population of patients.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Anhui Provincial Cancer Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| Beijing Tongren Hospital Affiliated to Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Gansu Cancer Hospital | Lanzhou, Gansu, China | Recruiting |
| Guangxi Zhuang Autonomous Region Cancer Hospital (Affiliated Cancer Hospital of Guangxi Medical University) | Nanning, Guangxi, China | Not Yet Recruiting |
| The First Affiliated Hospital of Hebei North University | Shijiazhuang, Hebei, China | Recruiting |
| Tianjin Cancer Hospital | Tianjin, Hebei, China | Recruiting |
| Henan Cancer Hospital | Zhengzhou, Henan, China | Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Recruiting |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Hubei Cancer Hospital | Wuhan, Hubei, China | Recruiting |
| Hunan Cancer Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University | Nanjing, Jiangsu, China | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05830500